Main Changes in Company’s Share Capital | Shares at a Discount | Preference Shares for More Than 20 years | Private Placement, Bonus Shares and GDRs | Alteration of Share Capital | Consolidation and Division of Shares
Category: Biotechnology
Directors And Their Powers in Accordance with The Companies Act, 2013
Directors And Their Powers | Maximum Number Of Directors | Maximum Number Of Directorship | Composition Of Board | Resignation Of Director | Vacancy Of Office For Not Attending Board Meetings | Disclosures In Board’s Report | Special Resolution
Patent Expirations & Biosimilar Drug Regulations In Pharmaceutical Industry: Regulatory Guidelines in India
Earlier this year, in Feb. 2012, FDA issued draft guidance on biosimilar product development, and The Patient Protection and Affordable Care Act, which was signed into law by President Obama on March 23, 2010, amended the Public Health Service Act to create an abbreviated approval pathway -- under section 351(k) -- for biological products that… Continue reading Patent Expirations & Biosimilar Drug Regulations In Pharmaceutical Industry: Regulatory Guidelines in India
Patent Lawyer: Legal Expert in Protecting Technology Innovations by Patents
Role of Patent Attorney in Protection of Business Ideas & Intangible Assets In present economic landscape, a crucial part of business involves enduring competition by securing strong intellectual property rights. Consequently, an important factor used during the valuation of a company is the strength and ownership of their intangible assets duly protected by solid and… Continue reading Patent Lawyer: Legal Expert in Protecting Technology Innovations by Patents
Isolated DNA Molecules used for Cancer Screening Are Patent Eligible
The Federal Circuit on July 29, 2011, held in a 2-1 decision that isolated BRCA1/2 DNA molecules used for diagnosing increased breast and ovarian cancer risk are eligible for patent protection under 35 U.S.C. §101. Association for Molecular Pathology v. USPTO, Fed. Cir., No. 2010-1406, 7/29/2011. In addition, the panel unanimously agreed that claims on… Continue reading Isolated DNA Molecules used for Cancer Screening Are Patent Eligible
NIH Stem Cell Injunction Vacated by the U.S. Court of Appeals for the D.C. Circuit
The federal government can continue funding research using human embryonic stem cells, the U.S. Court of Appeals for the D.C. Circuit ruled today, reversing a lower court injunction against the National Institutes of Health. Two scientists who work with adult stem cells sued NIH to stop embryonic stem cell research, charging that revised 2009 guidelines… Continue reading NIH Stem Cell Injunction Vacated by the U.S. Court of Appeals for the D.C. Circuit
Law Office of Rahul Dev 
You must be logged in to post a comment.